About this trial
Shoulder pain is a well-recognized complaint following laparoscopic surgery. It is underlying mechanism has various causes, therefore, modalities in management and prevention of this sort of pain are numerous with different success rates. In the light of this, the investigators aim to compare an anesthetic management plan involving using ketamine (which is a known intraoperative anesthetic agent) to another not involving it for participants undergoing gastric sleeve, and compare the incidence and intensity of shoulder pain afterwards.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients aged 18-60
American society of anesthesiologist grade 1,2
BMI > 40
BMI > 35 with obesity-related comorbidities
Disqualifiers
mentally incapacitated
patients received any type of analgesia 24hr preoperatively except paracetamol
history of drug abuse
patients with low ejection fraction
Trial design
Parallel
Treatments tested in this trial
Intraoperative ketamine
Drugintra-operative intravenous ketamine infusion in a dose of 0.3mg/kg/hour
Treatment groups
Trial outcomes
Primary outcomes
Postoperative analgesic effect of ketamine using VAS scale
The significance of this research is to assess the role of involving ketamine in the anesthetic plan intraoperatively in reducing postoperative shoulder pain in patients undergoing laparoscopic gastric sleeve. The visual analog scale (VAS) is a pain rating scale. Scores are based on self-reported measures of symptoms that are recorded were 0 there is no pain, and 10 is the worst pain.
Postoperative analgesic effect of ketamine using COMFORT scale
The Comfort scale is a behavioural method of measuring distress and pain. This scale has eight indicators: alertness, calmness / agitation, respiratory response, physical movement, blood pressure, heart rate, muscle tone, facial tension. Each indicator is scored between 1 and 5 based. Participants would be observed during the postoperative course. The total score can range between 8 to 40. A score of 17 to 26 generally indicates adequate sedation and pain control.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
King Abdullah University Hospital
Lead sponsor
Jordan University of Science and Technology
Sponsor institution
Jordan University of Science and Technology
Collaborator